September 17, 2024

‘One of the Most Impactful’ ESMO Studies: Durvalumab in Muscle-Invasive Bladder Cancer – Medscape

September 17, 2024

Combination Treatment Extends Survival in Advanced Bladder Cancer – Feinberg News Center

September 16, 2024

Dr Friedlander on AEs Associated With Enfortumab Vedotin in Bladder Cancer – OncLive

September 16, 2024

Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer – National Institutes of Health (NIH) (.gov)

September 16, 2024

Durvalumab regimen improves outcomes in muscle-invasive bladder cancer – Healio